Gain Therapeutics, Inc. (GANX): Shares Outstanding

Annual figures by period end, from SEC filings.

42.07M
As of 2025-12-31
43.34M
As of 2026-06-30
+52.4%
3-year compound annual growth
+64.0%
5-year compound annual growth
2020-12-31: 3.54M2021-12-31: 11.88M2022-12-31: 11.88M2023-12-31: 16.21M2024-12-31: 27.13M2025-12-31: 42.07M42.07M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3142.07M+55.1%2026-03-26, Balance as of period end
2024-12-3127.13M+67.4%2026-03-26, Balance as of period end
2023-12-3116.21M+36.4%2025-03-27, Balance as of period end
2022-12-3111.88M0.0%2024-03-26, Balance as of period end
2021-12-3111.88M+235.4%2023-03-23, Balance as of period end
2020-12-313.54Mn/a2022-03-25, Balance as of period end